GLPGF
Price:
$28.08
Market Cap:
$1.59B
Galapagos N.V. is a fully-integrated biopharmaceutical firm dedicated to discovering, developing, and bringing to market innovative therapies for conditions where patient needs are largely unaddressed. The company boasts a robust pipeline of investigational drugs, prominently featuring: Filgotinib: A potent JAK1 inhibitor, currently undergoing multiple phases of clinical evaluation for a broad spectrum of inflammatory and autoimmune disorders, such as rheumatoid arthritis, Crohn's disease (including small bowel and fistulizing forms), ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and uveitis. GLPG1972: This key candidate has successfully completed its Phase 2b trial target...[Read more]
Industry
Biotechnology
IPO Date
2009-08-03
Stock Exchange
OTC
Ticker
GLPGF
According to Galapagos N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.53B. This represents a change of -9.98% compared to the average of 1.70B of the last 4 quarters.
The mean historical Enterprise Value of Galapagos N.V. over the last ten years is 2.84B. The current 1.53B Enterprise Value has changed 5.27% with respect to the historical average. Over the past ten years (40 quarters), GLPGF's Enterprise Value was at its highest in in the December 2019 quarter at 10.02B. The Enterprise Value was at its lowest in in the September 2021 quarter at 151.35M.
Average
2.84B
Median
2.26B
Minimum
1.02B
Maximum
8.91B
Discovering the peaks and valleys of Galapagos N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 206.41%
Maximum Annual Enterprise Value = 8.91B
Minimum Annual Increase = -67.51%
Minimum Annual Enterprise Value = 1.02B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.76B | 4.06% |
| 2024 | 1.70B | -25.65% |
| 2023 | 2.28B | 2.22% |
| 2022 | 2.23B | 119.23% |
| 2021 | 1.02B | -67.51% |
| 2020 | 3.13B | -64.85% |
| 2019 | 8.91B | 206.41% |
| 2018 | 2.91B | 7.70% |
| 2017 | 2.70B | 49.03% |
| 2016 | 1.81B | 5.46% |
The current Enterprise Value of Galapagos N.V. (GLPGF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.91B
5-year avg
1.80B
10-year avg
2.84B
Galapagos N.V.’s Enterprise Value is less than Bavarian Nordic A/S (13.31B), less than Ryman Healthcare Limited (3.94B), less than Bavarian Nordic A/S (13.31B), less than Telix Pharmaceuticals Limited (5.37B), less than Gedeon Richter PLC (1.94T), less than Shandong Weigao Group Medical Polymer Company Limited (9.27B), less than MediPal Holdings Corporation (241.40B), less than Shandong Weigao Group Medical Polymer Company Limited (9.27B), less than Ansell Limited (3.62B), greater than Oxford Nanopore Technologies plc (1.02B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 13.31B | $2.15B | |
| 3.94B | $1.43B | |
| 13.31B | $2.15B | |
| 5.37B | $3.26B | |
| 1.94T | $7.19B | |
| 9.27B | $1.79B | |
| 241.40B | $3.41B | |
| 9.27B | $1.91B | |
| 3.62B | $2.97B | |
| 1.02B | $1.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galapagos N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Galapagos N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Galapagos N.V.'s Enterprise Value?
What is the highest Enterprise Value for Galapagos N.V. (GLPGF)?
What is the 3-year average Enterprise Value for Galapagos N.V. (GLPGF)?
What is the 5-year average Enterprise Value for Galapagos N.V. (GLPGF)?
How does the current Enterprise Value for Galapagos N.V. (GLPGF) compare to its historical average?